Novo Nordisk, Kennedy Institute Partner on Rheumatoid Arthritis Drug and … – Genetic Engineering News

April 24, 2012 by  
Filed under Osteo-Arthritis News

Novo Nordisk, Kennedy Institute Partner on Rheumatoid Arthritis Drug and
Genetic Engineering News
Novo Nordisk is partnering with Oxford University's Kennedy Institute of Rheumatology in the UK for the discovery and development of new biomarkers and drug targets for rheumatoid arthritis and other inflammatory autoimmune diseases.
Novo Nordisk, Oxford University In Joint Drug Devt DealFox Business

all 4 news articles »

More Info: Click here

“Finally, you can have the same Revolutionary Yoga Program top athletes use for TOTAL mind-body fitness ... in just 30 minutes a day!”

Speak Your Mind

Tell us what you're thinking...
and oh, if you want a pic to show with your comment, go get a gravatar!

This blog is kept spam free by WP-SpamFree.

Access denied for user ''@'localhost' (using password: NO)